Posts Tagged 'johnson and johnson'

Laparoscopic Uterine Power Morcellation Linked to Increased Cancer Risk

A Pennsylvania man is suing the manufacturer of a device used to remove large masses of tissue during minimally invasive surgeries. The man is alleging that the device caused the spread of cancerous tissue during his wife’s hysterectomy, ultimately resulting in her death. The device at issue is known as a morcellator, which operates by breaking up tissue into smaller fragments, allowing a surgeon to remove the tissue through a smaller incision than would be required in standard laparoscopic surgery.

On ...

continue reading...

Johnson & Johnson Settles $23 Million Lawsuit and Looks to Reestablish OTC Business

A story on Pharmalot reports a settlement of $23 million dollars against Johnson & Johnson for issues caused by their Fort Washington, Pennsylvania plant and its over-the-counter business as a whole. After practices at the Fort Washington plant resulted in numerous product recalls and a variety of quality control issues, shareholders filed a class action lawsuit over J&J’s poor managerial performance. The lawsuit alleged that management caused a decline in market share, congressional probes, and a loss of consumer confidence ...

continue reading...

Johnson & Johnson Guilty Plea Helps Risperdal Lawsuits

After a ten-year long criminal investigation, Johnson & Johnson has entered a guilty plea and will pay $2.2 billion in damages. The U.S. Department of Justice charged the company with promoting the drugs Risperdal and Invega for off-label uses (uses that were not approved by the FDA). These drugs were approved solely for the treatment of schizophrenia, but Johnson & Johnson was promoting them for non-schizophrenic patients—including children, ...

continue reading...

Personal Injury Attorneys Help to Save Lives: The Public Benefits of Litigation

It has recently been reported that Johnson & Johnson has decided to put red warning labels on bottles of Tylenol in order to inform users of the potentially fatal risks of acetaminophen overdose. This is a testament to the usefulness of products liability litigation.

The move by Johnson & Johnson can be considered a response to a growing number of lawsuits concerning liver injuries and deaths caused by acetaminophen overdose, as well as increased FDA scrutiny and safety proposals that ...

continue reading...

Johnson & Johnson Announces New Warnings For Extra Strength Tylenol

Risks of Liver Damage and Death Form Basis for Concern


Johnson & Johnson has announced that, beginning in October, bottles of Extra Strength Tylenol sold in the U.S. will be accompanied by new warnings and instructions. The warning will make it explicitly clear that the drug contains acetaminophen, a pain-relieving ingredient that is the nation’s leading cause of sudden liver failure. According to data from the Centers for Disease Control and Prevention and the Food and Drug Administration, ...

continue reading...

Government wants higher sanctions against Johnson & Johnson

The U.S. government is demanding that Johnson & Johnson add another $800 million to an initial proposal to settle a federal civil investigation into marketing of the anti-psychotic drug Risperdal, Bloomberg reports.

According to Bloomberg, the Justice Department is demanding that the company pay about $1.8 billion to resolve the civil claims by the U.S. and some states.

The demand came after the Justice Department and states decided a $1 billion settlement that had been negotiated by the U.S. Attorney’s office in ...

continue reading...
Page 11 of 11 «...7891011